,
,
,
,
,
,
,
,
,
,
All members of DAT'AIDS group gave their consent to be listed. Funding No funding was obtained for this study, 2017. ,
Contrôler durablement l'épidémie VIH en France, Bull Epidémiol Hebd, vol.18, pp.346-353, 2017. ,
Towards standardized definitions for monitoring the continuum of HIV care in Europe, AIDS Lond Engl, vol.31, pp.2053-2061, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01590423
The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices, J Acquir Immune Defic Syndr, vol.77, pp.31-40, 1999. ,
ANSM établit la RTU de Truvada dans la prophylaxie pré-exposition au VIH -Point d'information, 2015. ,
, La prophylaxie pré-exposition (PrEP) au VIH par TRUVADA, HAS, 2017.
Prise en charge médicale des personnes vivant avec le VIH: rapport, 2013. ,
Truvada dans la prophylaxie Pré-exposition (PrEP) au VIH : fin de la Recommandation Temporaire d'Utilisation -Informations importantes concernant le bon usage de Truvada® dans l'indication « Prophylaxie préexposition (PrEP) » au VIH -Brochure destinée aux prescripteurs, 2017. ,
Infection par le VIH et IST bactériennes, Inst Veille Sanit Santé Publique Fr, vol.26, 2018. ,
A large French prospective cohort of HIV-infected patients: the Nadis cohort, HIV Med, vol.10, pp.504-515, 2009. ,
Missed opportunities to prescribe Preexposure prophylaxis in South Carolina, Clin Infect Dis Off Publ Infect Dis Soc Am, pp.2013-2016, 2018. ,
Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)?, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.22, 2017. ,
Dynamics of the HIV epidemic in MSM, Biomed Res Int, p.497543, 2014. ,
HIV epidemic among men who have sex with men in the Czech Republic, 2016: high time for targeted action, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.22, 2017. ,
HIV incidence among gay men and other men who have sex with men in 2020: where is the epidemic heading? Sex Health, vol.14, pp.5-17, 2017. ,
Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, Sex Transm Infect, pp.2013-2016, 2018. ,
Low levels of chemsex among men who have sex with men, but high levels of risk among men who engage in chemsex: analysis of a cross-sectional online survey across four countries, Sex Health, vol.15, pp.144-50, 2018. ,
Sexualized drug use (Chemsex) is associated with high-risk sexual behaviors and sexually transmitted infections in HIV-positive men who have sex with men: data from the U-SEX GESIDA 9416 study, AIDS Patient Care STDs, vol.32, pp.112-120, 2018. ,
Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics, HIV Med, 2018. ,
Increasing use of "party drugs" in people living with HIV on antiretrovirals: a concern for patient safety, AIDS Lond Engl, vol.29, pp.1585-92, 2015. ,
Drug-drug interactions: antiretroviral drugs and recreational drugs, Recent Patents CNS Drug Discov, vol.9, pp.153-63, 2014. ,
Prevalence of drug-drug interactions in the era of HIV integrase inhibitors: a retrospective clinical study, Neth J Med, vol.75, pp.235-275, 2017. ,
Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men, AIDS Lond Engl, vol.30, pp.2251-2253, 2016. ,
Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services, JAMA Intern Med, vol.176, pp.75-84, 2016. ,
Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV, AIDS Lond Engl, vol.32, pp.523-553, 2018. ,
Sexually transmitted infections and pre-exposure prophylaxis: challenges and opportunities among men who have sex with men in the US, AIDS Res Ther, vol.13, p.5, 2016. ,
Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report, J Med Case Rep, vol.9, p.207, 2015. ,
The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B, J Acquir Immune Defic Syndr, vol.71, pp.281-286, 1999. ,
Australasian society for HIV, viral hepatitis and sexual health medicine HIV pre-exposure prophylaxis: clinical guidelines. Update, J Virus Erad, vol.4, pp.143-59, 2018. ,
Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men, J Acquir Immune Defic Syndr, vol.72, pp.61-67, 1999. ,
, ANSM. Suivi de l'utilisation de Truvada® ou génériques pour une prophylaxie pré-exposition (PrEP) au VIH à partir du SNIIRAM, 2018.
Modified social ecological model: a tool to guide the assessment of the risks and risk contexts of HIV epidemics, BMC Public Health, vol.13, p.482, 2013. ,
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study, BMC Infect Dis, vol.13, 0200. ,
URL : https://hal.archives-ouvertes.fr/inserm-00822062
The persistent problem of late HIV diagnosis in people with AIDS: a populationbased study in Italy, Public Health, vol.142, pp.39-45, 2017. ,
Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better, Swiss Med Wkly, vol.146, p.14348, 2016. ,
Late HIV presentationmissed opportunities and factors associated with a changing pattern over time, Int J STD AIDS, vol.28, pp.814-835, 2017. ,
Scale-up of Preexposure prophylaxis in San Francisco to impact HIV incidence, 2015. ,